Business / Finance

RSS

Saluda Medical receives $10 million in Series B financing

Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain one step closer to reality.

20 Feb 2015

Ready to reconstitute BPW adds convenient option to support high throughput Salmonella testing in chocolate production

The discovery of Salmonella in one batch of a particular chocolate product, which prompted a recent recall, is a reminder of the importance of this pathogen in confectionery products.

20 Feb 2015

Georgia State signs license agreement with Cisen to develop compounds for treating cancer

Georgia State University has signed a license agreement with Cisen Pharmaceutical Co. Ltd., a comprehensive pharmaceutical enterprise in China, to develop cancer-fighting compounds designed by Georgia State researcher Dr. Binghe Wang, in collaboration with Professor Muxiang Zhou of Emory University, a cancer biologist.

20 Feb 2015

VirMedica acquires assets of TransEngen

VirMedica, a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced today that VirMedica, Inc. has acquired the assets of TransEngen, Inc. The $15 million dollar financing was led by Nashville-based Petra Capital Partners along with Menlo Park-based HealthQuest Capital.

19 Feb 2015

IDRI Announces $4M BARDA Cooperative Agreement To Establish Adjuvant Hub

The international outbreak of Ebola in 2014 serves as a reminder for the need to be proactive in preparing for the rapid spread of any newly emerging or re-emerging infectious disease. IDRI today announces it has received $4 million in funding from the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to develop an adjuvant manufacturing hub with both preclinical and clinical expertise to facilitate pandemic influenza preparedness in developing countries.

19 Feb 2015

Adeptus Health's net revenue increases 108.0% to $70.1 million in fourth quarter 2014

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., announced its results for the fourth quarter and full year ended December 31, 2014.

19 Feb 2015

Excellere Partners completes sale of U.S. Water Services to Allete

Excellere Partners, a Denver-based private equity firm focused on partnering with middle-market entrepreneurs and management teams, announced today that it completed the sale of its portfolio company U.S. Water Services, Inc., to Allete on February 10, 2015.

19 Feb 2015

Lupin introduces new InspiraChamber VHC under strategic licensing agreement with InspiRX

Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the all new InspiraChamber Anti-Static Valved Holding Chamber (VHC) under a strategic licensing agreement with the New Jersey based respiratory research and development company InspiRX Inc.

19 Feb 2015

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and year ended December 31, 2014, including a summary of recent corporate highlights.

19 Feb 2015

PipelineRx receives support from CHCF to help improve quality of patient care

PipelineRx, a leading clinical telepharmacy platform company supporting medication management, today announced continuing support from the California HealthCare Foundation to help improve quality of care by expanding ways pharmacists can be accessible to more patients in the acute setting.

19 Feb 2015

Epic Health Services acquires Loving Care Agency

Epic Health Services Inc., a portfolio company of Webster Capital and Dallas-based provider of pediatric skilled nursing and therapy, announced today the completion of its acquisition of the parent company and pediatric division of Loving Care Agency, Inc., a provider of pediatric and adult home health care services based in Hasbrouck Heights, New Jersey.

19 Feb 2015

Dance Biopharm announces completion of $9.5 million convertible note and warrants financing

Dance Biopharm Inc., a privately-held biotechnology company focused on the development of inhaled insulin products to treat diabetes, today announced the completion of a $9.5 million convertible note and warrants financing.

19 Feb 2015

TE Connectivity signs definitive agreement to acquire AdvancedCath

TE Connectivity Ltd., a world leader in connectivity, announced today that it has entered into a definitive agreement to acquire AdvancedCath for $190 million USD in cash.

19 Feb 2015

Caris Life Sciences announces record-setting revenue for 2014

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced select year-end financial and operational results for 2014, which include record-setting revenue and continued case volume growth for its panomic, comprehensive tumor profiling service, Caris Molecular Intelligence.

18 Feb 2015

NJHF, Princeton University partner for breakthrough biomedical research

New Jersey Health Foundation is pleased to announce the signing of an affiliation agreement with the Office of Technology Licensing (OTL) at Princeton University that allows both organizations to work together to develop opportunities to advance breakthrough biomedical research being conducted at Princeton.

18 Feb 2015

Capital Impact Partners' fourth quarter lending to projects tops $45 million

Capital Impact Partners announced today that its 2014 fourth quarter lending to projects in underserved communities topped $45 million. Highlights of this financing included continued Capital Impact leadership in funding Federally Qualified Health Center (FQHC) projects to increase the availability of healthcare to low income residents; supporting inclusive housing growth in Detroit by closing the first loan through the organization's partnership with JPMorgan Chase & Co.; and leveraging New Markets Tax Credits (NMTC) to support a variety of projects.

18 Feb 2015

AirStrip, Life Monitor form alliance to sell AirStrip solutions in New Zealand and Australia

AirStrip and Life Monitor Pty Ltd., a subsidiary of Cardioscan Pty Ltd., today announced the formation of a strategic partnership to sell AirStrip solutions in Australia and New Zealand. Both the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system will be available as part of the agreement.

18 Feb 2015

Innophos Holdings' net sales decrease 1% to $194 million in fourth quarter 2014

Innophos Holdings, Inc., a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets, today announced its financial results for the fourth quarter and full year 2014.

18 Feb 2015

PVA TePla America forms global strategic partnership with Integrated Surface Technologies

PVA TePla America, Inc., a subsidiary of PVA TePla AG announced today it has formed a global strategic alliance with Integrated Surface Technologies MENLO PARK, CA. The alliance will leverage the global sales, contract services, field service and development resources of PTA and IST's silane surface chemistry technologies as well as atomic layer deposition techniques.

18 Feb 2015

Boston Scientific, Johnson & Johnson settle breach of merger agreement lawsuit

Boston Scientific Corporation today announced the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson against Guidant Corporation, stemming from Boston Scientific's acquisition of Guidant.

18 Feb 2015